Ercros's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.11.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.40.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Ercros's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ercros was 499.10% per year. The lowest was -85.60% per year. And the median was 16.60% per year.
CHIX:ECRe's 3-Year EBIT Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.2 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Ercros's EBIT for the
three
months ended in Mar. 2026 was €-9.8 Mil.
Ercros (CHIX:ECRe) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Ercros EBIT per Share Related Terms
Ercros EBIT per Share Historical Data
* Premium members only.
The historical data trend for Ercros's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ercros (CHIX:ECRE) has a EBIT per Share of €-0.40 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ercros and its competitors. According to the industry distribution chart, Ercros ranks #999999 out of 1339 companies in the Chemicals industry.
Is Ercros' EBIT per Share too high?
Ercros' current EBIT per Share is €-0.40. Based on the distribution chart, Ercros ranks #999999 out of 1339 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Ercros has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Ercros' EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Ercros ranks #999999 out of 1339 companies for EBIT per Share. This places Ercros in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ercros and its competitors. Ercros's current EBIT per Share is €-0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ercros stock overvalued right now?
Ercros (CHIX:ECRE) has a current EBIT per Share of €-0.40. The stock's GF Value™ is €2.94, compared to a current price of €3.40 — trading 15.5% above its estimated fair value. The current EBIT per Share is €-0.40. Ercros' overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Ercros (CHIX:ECRE), the current EBIT per Share is €-0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ercros (CHIX:ECRE) Overvalued in 2026?
Based on GuruFocus' analysis, Ercros stock appears to be overvalued.
The current stock price of €3.40 is trading 15.5% above its estimated GF Value™ of €2.94.
Key valuation signals for CHIX:ECRE:
EBIT per Share: €-0.40
GF Value™: €2.94 vs. price of €3.40 (15.5% above fair value)
No single metric tells the full story. See the CHIX:ECRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.
68GF Score
Get the complete analysis for CHIX:ECRE
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ECRE has been successfully added to your 
